Sir Andrew Witty, chief executive officer (CEO) of GlaxoSmithKline visited the CMAC National Facility on Monday 22nd Feb 2016. There were presentations and discussions on the research, skills, facilities and key industry translation activities followed by a tour of the facilities. He was accompanied by the Principal of University of Strathclyde Professor Sir Jim McDonald, Scottish Enterprise and senior representatives from GSK. Sir Andrew and his team were very complimentary and were impressed by the range of activities and people they met. He commented that CMAC was an exemplar of critical mass research activities.
